barr 250 mg 1075 Pill - white capsule/oblong
Pill with imprint barr 250 mg 1075 is White, Capsule/Oblong and has been identified as Temozolomide 250 mg. It is supplied by Teva Pharmaceuticals USA Inc.
Temozolomide is used in the treatment of Glioblastoma Multiforme; Anaplastic Astrocytoma and belongs to the drug class alkylating agents. There is positive evidence of human fetal risk during pregnancy. Temozolomide 250 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for barr 250 mg 1075
Temozolomide
- Imprint
- barr 250 mg 1075
- Strength
- 250 mg
- Color
- White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Alkylating agents
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Teva Pharmaceuticals USA Inc.
- National Drug Code (NDC)
- 00093-7602 (Discontinued)
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
povidone k30,
sodium starch glycolate type A potato,
stearic acid,
tartaric acid,
D&C Yellow No. 10,
FD&C Red No. 40,
FD&C Yellow No. 6,
gelatin,
titanium dioxide,
ferrosoferric oxide,
aluminum oxide,
FD&C Blue No. 1,
FD&C Blue No. 2,
indigotindisulfonate sodium,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about temozolomide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (10)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- En español
Patient resources
- Temozolomide oral/injection drug information
- Temozolomide (Intravenous) (Advanced Reading)
- Temozolomide (Oral) (Advanced Reading)
- Temozolomide Capsules
- Temozolomide Injection
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
